The invention relates to iRNA agents, which preferably include a monomer in which the ribose moiety has been replaced by a moiety other than ribose that further includes a tether having one or more linking groups, in which at least one of the linking groups is a cleavable linking group. The tether in turn can be connected to a selected moiety, e.g., a ligand, e.g., a targeting or delivery moiety, or a moiety which alters a physical property. The cleavable linking group is one which is sufficiently stable outside the cell such that it allows targeting of a therapeutically beneficial amount of an iRNA agent (e.g., a single stranded or double stranded iRNA agent), coupled by way of the cleavable linking group to a targeting agent--to targets cells, but which upon entry into a target cell is cleaved to release the iRNA agent from the targeting agent.

 
Web www.patentalert.com

< Polyphosphazine-based polymer materials

< Modulation of apolipoprotein (A) expression

> Oligonucleotides comprising a non-phosphate backbone linkage

> Display device producing display by changing shape of refractive index ellipsoid of medium by applying electric field to medium

~ 00612